Healthcare provider profile · identity verified

Youssef Siage, MD

Internal Medicine · CHARLOTTE, NC · NPI 1346386190

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	570	158
Amlodipine Besylate	Amlodipine Besylate	352	110
Rosuvastatin Calcium	Rosuvastatin Calcium	264	83
Levothyroxine Sodium	Levothyroxine Sodium	231	66
Lisinopril	Lisinopril	193	57
Losartan Potassium	Losartan Potassium	164	50
Omeprazole	Omeprazole	158	51
Fluticasone Propionate	Fluticasone Propionate	149	58
Pantoprazole Sodium	Pantoprazole Sodium	149	43
Metoprolol Succinate	Metoprolol Succinate	148	45
Metformin Hcl	Metformin Hcl	136	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	131	34
Metformin Hcl Er	Metformin Hcl	128	34
Gabapentin	Gabapentin	126	36
Hydrochlorothiazide	Hydrochlorothiazide	125	37
Carvedilol	Carvedilol	123	40
Albuterol Sulfate Hfa	Albuterol Sulfate	112	52
Tamsulosin Hcl	Tamsulosin Hcl	101	34
Trazodone Hcl	Trazodone Hcl	95	27
Finasteride	Finasteride	94	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	26
Meloxicam	Meloxicam	90	28
Simvastatin	Simvastatin	87	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	16
Tizanidine Hcl	Tizanidine Hcl	77	24
Furosemide	Furosemide	74	27
Pravastatin Sodium	Pravastatin Sodium	72	15
Montelukast Sodium	Montelukast Sodium	70	23
Potassium Chloride	Potassium Chloride	69	20
Famotidine	Famotidine	67	22
Escitalopram Oxalate	Escitalopram Oxalate	64	22
Ozempic	Semaglutide	64	12
Olmesartan Medoxomil	Olmesartan Medoxomil	62	21
Allopurinol	Allopurinol	60	19
Glimepiride	Glimepiride	60	16
Eliquis	Apixaban	57	16
Spironolactone	Spironolactone	55	15
Metoprolol Tartrate	Metoprolol Tartrate	52	14
Citalopram Hbr	Citalopram Hydrobromide	50	18
Pioglitazone Hcl	Pioglitazone Hcl	50	13
Tramadol Hcl	Tramadol Hcl	50	13
Lorazepam	Lorazepam	49	16
Mounjaro	Tirzepatide	46	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	17
Clopidogrel	Clopidogrel Bisulfate	44	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Alprazolam	Alprazolam	40	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	17
Sertraline Hcl	Sertraline Hcl	38	16
Celecoxib	Celecoxib	37	11
Lovastatin	Lovastatin	37	suppressed
Prednisone	Prednisone	34	30
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Xarelto	Rivaroxaban	33	suppressed
Trulicity	Dulaglutide	32	suppressed
Ibandronate Sodium	Ibandronate Sodium	31	12
Bupropion Xl	Bupropion Hcl	30	suppressed
Linzess	Linaclotide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	16
Fluconazole	Fluconazole	24	17
Glipizide Er	Glipizide	24	suppressed
Ketoconazole	Ketoconazole	24	19
Klor-Con M20	Potassium Chloride	24	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Ramipril	Ramipril	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Valsartan	Valsartan	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	14
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Atenolol	Atenolol	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Risedronate Sodium	Risedronate Sodium	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error